UK Markets open in 4 hrs 40 mins
  • NIKKEI 225

    27,630.95
    +112.70 (+0.41%)
     
  • HANG SENG

    20,232.73
    +448.08 (+2.26%)
     
  • CRUDE OIL

    73.76
    +0.56 (+0.77%)
     
  • GOLD FUTURES

    1,968.80
    -4.70 (-0.24%)
     
  • DOW

    32,394.25
    -37.83 (-0.12%)
     
  • BTC-GBP

    22,145.75
    +205.47 (+0.94%)
     
  • CMC Crypto 200

    599.67
    +356.99 (+147.10%)
     
  • Nasdaq

    11,716.08
    -52.76 (-0.45%)
     
  • ^FTAS

    4,072.46
    +1.39 (+0.03%)
     

Blood Gas and Electrolyte Analyzers Global Market Report 2023

ReportLinker
ReportLinker

Major players in the blood gas and electrolyte analyzers market are OPTI Medical Systems Inc., EDAN Instruments Inc., The Samsung Group, Radiometer Medical ApS, Novastat, Erba Mannheim, Roche Holding AG, Medica Corp, Siemens AG, Abbott Laboratories, Roche Diagnostics, Instrumentation Laboratory, Alere Inc.

New York, March 03, 2023 (GLOBE NEWSWIRE) -- Reportlinker.com announces the release of the report "Blood Gas and Electrolyte Analyzers Global Market Report 2023" - https://www.reportlinker.com/p06290020/?utm_source=GNW
, Dalko Diagnostics, Erba.

The global blood gas and electrolyte analyzers market grew from $3 billion in 2022 to $3.18 billion in 2023 at a compound annual growth rate (CAGR) of 6.0%. The Russia-Ukraine war disrupted the chances of global economic recovery from the COVID-19 pandemic, at least in the short term. The war between these two countries has led to economic sanctions on multiple countries, a surge in commodity prices, and supply chain disruptions, causing inflation across goods and services and affecting many markets across the globe. The blood gas and electrolyte analyzers market is expected to grow to $4.13 billion in 2027 at a CAGR of 6.8%.

The blood gas and electrolyte analyzers market consist of sales of blood oxygen analyzer, full-automatic blood gas analyzer, tissue oxygen content measuring instrument, handheld blood gas analyzer, blood gas collector, semi-automatic electrolyte analyzer, potassium analyzer and fully automatic electrolyte analyzer.Values in this market are ‘factory gate’ values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors and retailers) or directly to end customers.

The value of goods in this market includes related services sold by the creators of the goods.

The blood gas and electrolyte analyzers are used to measure combinations of pH, blood gas, electrolytes, and metabolites parameters from whole blood samples. Electrolytes are measured in the clinical laboratories in both serum and whole blood samples received for arterial blood gas (ABG) analysis.

North America was the largest region in the blood gas and electrolyte analyzers market in 2022 and is also expected to be the fastest-growing region in the forecast period. The regions covered in the blood gas and electrolyte analyzers market is report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, and Africa.

The main blood gas and electrolyte analyzer products are blood gas analyzers, electrolyte analyzers, combined analyzers, and consumables.Blood gas analyzers are utilized to measure blood gas, pH, electrolytes, and some metabolites in entire blood specimens.

They can calculate pH, carbon dioxide and oxygen partial pressures, and the concentrations of a variety of ions and metabolites.Blood gas and electrolyte analyzers are of various modalities such as portable, laboratory, and benchtop.

Blood gas and electrolyte analyzers are used by end-use such as central laboratories, point-of-care, diagnostic centers, hospitals, and other end-users.

The increase in the number of patients led to more blood sample testing, contributing to the growth of the blood gas and electrolyte analyzers market.Blood tests are used for a variety of purposes, including determining cholesterol and blood glucose levels.

These can help keep track of the risk of heart disease, vascular disease, and diabetes, as well as how well the problem is treated. For instance, in 2021, of the 118.5 million blood donations received worldwide, 40% are collected in high-income countries, which account for 16% of the global population. Children under the age of five years old receive up to 54% of blood transfusions in low-income nations, but in high-income countries, the most frequently transfused patient group is over 60 years old, accounting for up to 75% of all transfusions. Thus, the increase in the number of patients led to more blood sample testing is contributing to the growth of the blood gas and electrolyte analyzers market

Increasing technological advancements are a key trend gaining popularity in the blood gas and electrolyte analyzers market.Blood gas analysis is typically used in hospital point of care (POC) settings, where easily and accurate results are required.

This involves emergency rooms, intensive care units, and operating rooms.For instance, in 2020, Swiss multinational healthcare company, Roche introduced the CE mark availability of Roche v-TAC, a new digital diagnostic solution that provides clinicians to achieve results for arterial blood gas values from patients with respiratory or metabolic abnormalities through the same, less invasive venous puncture by the utilized of a digital algorithm.

The analysis allows clinicians with information about a patient’s pulmonary function and acid?base status, both of which are required to make a diagnosis, allow treatment, and monitor progress.

In May 2020, Roche Holding, the Switzerland-based research healthcare company engaged in the discovery, development, and commercialization of pharmaceuticals and diagnostics, acquired Obi Medical for an undisclosed amount.This acquisition will help Roche to improve Roche v-TAC, a digital diagnostic solution that provides medical institutions to achieve results for arterial blood gas values in the same manner.

The Roche v-TAC has been improved by integrating Roche’s Cobas infinity point of care solutions & Obi’s v-TAC technology. Obi Medical is a Denmark-based company engaged in manufacturing v-Tac software for blood gas testing that manufacturers blood gas and electrolyte analyzers

The countries covered in the blood gas and electrolyte analyzers market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD, unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

The blood gas and electrolyte analyzers market research report is one of a series of new reports that provides blood gas and electrolyte analyzers market statistics, including blood gas and electrolyte analyzers industry global market size, regional shares, competitors with a blood gas and electrolyte analyzers market share, detailed blood gas and electrolyte analyzers market segments, market trends and opportunities, and any further data you may need to thrive in the blood gas and electrolyte analyzers industry. This blood gas and electrolyte analyzers market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
Read the full report: https://www.reportlinker.com/p06290020/?utm_source=GNW

About Reportlinker
ReportLinker is an award-winning market research solution. Reportlinker finds and organizes the latest industry data so you get all the market research you need - instantly, in one place.

__________________________

CONTACT: Clare: clare@reportlinker.com US: (339)-368-6001 Intl: +1 339-368-6001